Patents by Inventor Subramanian Baskaran

Subramanian Baskaran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10294214
    Abstract: Disclosed herein are positive allosteric modulators of melanocortin receptor and methods of using such modulators.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: May 21, 2019
    Assignees: Vanderbilt University, King's College London, Glaxo Group Limited
    Inventors: Roger D. Cone, Michael J. Bishop, Eugene L. Stewart, Lawrence A. Wolfe, Jaques Pantel, Julien Sebag, C. David Weaver, Savannah Williams, Helen Cox, Iain Tough, Luis Diaz Gimenez, Subramanian Baskaran
  • Publication number: 20170349571
    Abstract: Disclosed herein are positive allosteric modulators of melanocortin receptor and methods of using such modulators.
    Type: Application
    Filed: June 7, 2017
    Publication date: December 7, 2017
    Inventors: Roger D. Cone, Michael J. Bishop, Eugene L. Stewart, Lawrence A. Wolfe, Jaques Pantel, Julien Sebag, C. David Weaver, Savannah Williams, Helen Cox, Ian Tough, Luis Diaz Gimenez, Subramanian Baskaran
  • Patent number: 9513874
    Abstract: Various technologies related to an enterprise computing platform are presented. Documents in a framework can be edited via logical views as described. An enterprise computing platform having a variety of frameworks can be configured to operate in a variety of business domains. Features such as parallel computing, distributed computing, logical documents, document transformation, space visualization, data security, and others can be accomplished via configuration rather than coding.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: December 6, 2016
    Assignee: Infosys Limited
    Inventors: Dinesh Govind Joshi, Mahesh Huyilalu Shivaram, Ganesan Kaushik, Subramanian Baskaran, Vinoop Aradhya
  • Patent number: 8889726
    Abstract: Disclosed are compounds of Formula I, Formula II, and Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: November 18, 2014
    Assignee: GlaxoSmithKline LLC
    Inventors: Subramanian Baskaran, Richard Martin Grimes, Wieslaw Mieczyslaw Kazmierski, Martin Robert Leivers
  • Publication number: 20140171476
    Abstract: Disclosed are compounds of Formula I, Formula II, and Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.
    Type: Application
    Filed: August 6, 2012
    Publication date: June 19, 2014
    Applicant: GlaxoSmith Kline LLC
    Inventors: Subramanian Baskaran, Richard Martin Grimes, Wieslaw Mieczyslaw Kazmierski, Martin Robert Leivers
  • Publication number: 20130047135
    Abstract: Various technologies related to an enterprise computing platform are presented. A new level of software development can be achieved by avoiding the coding process. An enterprise computing platform having a variety of frameworks can be configured to operate in a variety of business domains. Features such as parallel computing, distributed computing, logical documents, document transformation, space visualization, data security, and others can be accomplished via configuration rather than coding. Considerable efficiency improvements in the software development process can be realized.
    Type: Application
    Filed: November 29, 2011
    Publication date: February 21, 2013
    Applicant: Infosys Limited
    Inventors: Dinesh Govind Joshi, Mahesh Huyilalu Shivaram, Ganesan Kaushik, Subramanian Baskaran, Vinoop Aradhya
  • Publication number: 20120121540
    Abstract: Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
    Type: Application
    Filed: August 8, 2008
    Publication date: May 17, 2012
    Inventors: Franz Ulrich Schmitz, Vincent W.F Tai, Roopa Ral, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Subramanian Baskaran, Irina Slobodov, Jack Maung, Martin Leon Neitzel
  • Publication number: 20100272680
    Abstract: Provided are compounds of Formula (I) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).
    Type: Application
    Filed: February 9, 2010
    Publication date: October 28, 2010
    Inventors: Subramanian Baskaran, Jack Maung, Martin Neitzel, Rai Roopa, Christopher Roberts, Vincent Tai
  • Publication number: 20100204265
    Abstract: Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
    Type: Application
    Filed: February 9, 2009
    Publication date: August 12, 2010
    Inventors: Subramanian Baskaran, Jack Maung, Martin Leon Neitzel, Roopa Rai, Irina Slododov, Vincent W-F Tai
  • Publication number: 20100179123
    Abstract: The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
    Type: Application
    Filed: October 8, 2009
    Publication date: July 15, 2010
    Applicant: Sunesis Pharmaceuticals, Inc.
    Inventors: Willard Lew, Subramanian Baskaran, Johan D. Oslob, Joshua C. Yoburn, Min Zhong
  • Patent number: 7601725
    Abstract: The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
    Type: Grant
    Filed: July 15, 2005
    Date of Patent: October 13, 2009
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Willard Lew, Subramanian Baskaran, Johan D. Oslob, Joshua C. Yoburn, Min Zhong
  • Publication number: 20090176778
    Abstract: Provided are certain chemical entities, pharmaceutical compositions, and methods of treatment of a member of the flaviviradae family of viruses such as hepacivirus (Hepatitis C or HCV).
    Type: Application
    Filed: August 8, 2008
    Publication date: July 9, 2009
    Inventors: Franz Ulrich Schmitz, Vincent W-F Tai, Roopa Rai, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Subramanian Baskaran, Irina Slobodov, Jack Maung, Martin Leon Neitzel
  • Patent number: 7244830
    Abstract: A glycopolymer composition is provided comprising glycopolymer molecules having a polymer backbone; a first pendent unit comprising a linking group connected to said polymer backbone and a saccharide moiety connected to said linking group, optionally a second pendent unit; a phenyl ring at a first end of the polymer backbone; and a cyanoxyl group at the second end of the polymer backbone, useful as intermediates for making bioactive glycopolymers which bind to bioactive molecules, viruses, cells and substrates for protein separation, cell culture, ad drug delivery systems, as well as in targeting for treatment of wound healing and other pathological conditions.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: July 17, 2007
    Assignee: Emory University
    Inventors: Elliot L. Chaikof, Daniel Grande, Subramanian Baskaran
  • Publication number: 20060035908
    Abstract: The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasess herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
    Type: Application
    Filed: July 15, 2005
    Publication date: February 16, 2006
    Inventors: Willard Lew, Subramanian Baskaran, Johan Oslob, Joshua Yoburn, Min Zhong
  • Publication number: 20040116677
    Abstract: A glycopolymer composition is provided comprising glycopolymer molecules having a polymer backbone; a first pendent unit comprising a linking group connected to said polymer backbone and a saccharide moiety connected to said linking group, optionally a second pendent unit; a phenyl ring at a first end of the polymer backbone; and a cyanoxyl group at the second end of the polymer backbone, useful as intermediates for making bioactive glycopolymers which bind to bioactive molecules, viruses, cells and substrates for protein separation, cell culture, ad drug delivery systems, as well as in targeting for treatment of wound healing and other pathological conditions.
    Type: Application
    Filed: November 24, 2003
    Publication date: June 17, 2004
    Inventors: Elliot L. Chaikof, Daniel Grande, Subramanian Baskaran